Arcadia Biosciences (RKDA) Misses Q2 EPS by 3c
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $721 thousand versus the consensus estimate of $1.9 million.
For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agree Realty (ADC) Tops Q3 FFO by 4c
- Intersil Corp (ISIL) Tops Q3 EPS by 4c
- Buckeye Partners (BPL) Tops Q3 EPS by 22c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!